CN114630653B - 经压缩的烟碱锭剂 - Google Patents

经压缩的烟碱锭剂

Info

Publication number
CN114630653B
CN114630653B CN202080070762.2A CN202080070762A CN114630653B CN 114630653 B CN114630653 B CN 114630653B CN 202080070762 A CN202080070762 A CN 202080070762A CN 114630653 B CN114630653 B CN 114630653B
Authority
CN
China
Prior art keywords
water
nicotine
layer
soluble
oral nicotine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080070762.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN114630653A (zh
Inventor
布鲁诺·普罗夫斯特高·涅尔森
多尔特·沙克尔·伯森
海迪·齐格勒·布鲁恩
肯特·阿尔宾·涅尔森
瑞克·普兰杰-拉斯穆森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fertin Pharma AS
Original Assignee
Fertin Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma AS filed Critical Fertin Pharma AS
Publication of CN114630653A publication Critical patent/CN114630653A/zh
Application granted granted Critical
Publication of CN114630653B publication Critical patent/CN114630653B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202080070762.2A 2019-10-11 2020-04-17 经压缩的烟碱锭剂 Active CN114630653B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/599,629 US11759419B2 (en) 2019-10-11 2019-10-11 Compressed nicotine lozenge
US16/599,629 2019-10-11
PCT/DK2020/050103 WO2021069036A1 (en) 2019-10-11 2020-04-17 Compressed nicotine lozenge

Publications (2)

Publication Number Publication Date
CN114630653A CN114630653A (zh) 2022-06-14
CN114630653B true CN114630653B (zh) 2026-01-30

Family

ID=70464804

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080070762.2A Active CN114630653B (zh) 2019-10-11 2020-04-17 经压缩的烟碱锭剂

Country Status (17)

Country Link
US (2) US11759419B2 (https=)
EP (2) EP4445897A3 (https=)
JP (1) JP7574286B2 (https=)
KR (1) KR20220080165A (https=)
CN (1) CN114630653B (https=)
AU (2) AU2020363748B2 (https=)
BR (1) BR112022006691A2 (https=)
CA (1) CA3154225A1 (https=)
DK (1) DK3923910T3 (https=)
ES (1) ES2991040T3 (https=)
FI (1) FI3923910T3 (https=)
MX (1) MX2022004349A (https=)
MY (1) MY206865A (https=)
PL (1) PL3923910T3 (https=)
UA (1) UA129748C2 (https=)
WO (1) WO2021069036A1 (https=)
ZA (1) ZA202204081B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
JP2026509969A (ja) * 2023-01-27 2026-03-26 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 活性成分の経口送達のためのシステム
WO2024156323A1 (en) * 2023-01-27 2024-08-02 Fertin Pharma A/S An adhesive oral disc for sustained release of cannabinoids
WO2025011727A1 (en) * 2023-07-07 2025-01-16 Fertin Pharma A/S Dissolvable orally adhering nicotine tablet
KR20250033557A (ko) * 2023-08-31 2025-03-10 주식회사 케이티앤지 니코틴 파우치 충진제 및 이의 제조방법
KR20250033558A (ko) * 2023-08-31 2025-03-10 주식회사 케이티앤지 니코틴 파우치 충진제 및 이의 제조방법
KR20250033563A (ko) * 2023-08-31 2025-03-10 주식회사 케이티앤지 니코틴 파우치 충진제 및 이의 제조방법
EP4543417A1 (en) * 2023-09-12 2025-04-30 Fertin Pharma A/S Orally disintegrating nicotine tablet for use under lip
CN121445113A (zh) * 2024-08-02 2026-02-03 深圳市吉迩科技有限公司 一种尼古丁组合物及其制备方法、尼古丁制品
WO2026057139A1 (en) * 2024-09-12 2026-03-19 Fertin Pharma A/S Fast dissolvable solid oral dosage form

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010044736A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
CA2758618C (en) 2009-04-24 2017-03-28 Omya Development Ag Particulate material for controlled release of active ingredients
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
CA2916077C (en) 2015-12-22 2023-06-20 Euro-Pharm International Canada Inc. Nicotine-containing solid oral formulations and uses thereof
RU2736072C1 (ru) 2016-11-18 2020-11-11 Фертин Фарма А/С Таблетка, содержащая отдельное связывающее вещество и эритрит
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
ES2975449T3 (es) 2017-05-22 2024-07-05 Johnson & Johnson Consumer Inc Forma farmacéutica de pastilla

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010044736A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof

Also Published As

Publication number Publication date
EP4445897A2 (en) 2024-10-16
MX2022004349A (es) 2022-06-08
PL3923910T3 (pl) 2024-11-18
AU2020363748B2 (en) 2024-04-11
US12478579B2 (en) 2025-11-25
ES2991040T3 (es) 2024-12-02
EP3923910A1 (en) 2021-12-22
FI3923910T3 (fi) 2024-10-24
DK3923910T3 (da) 2024-11-11
ZA202204081B (en) 2024-08-28
EP3923910B1 (en) 2024-09-11
UA129748C2 (uk) 2025-07-23
JP2022551314A (ja) 2022-12-08
BR112022006691A2 (pt) 2022-07-12
AU2024201729B2 (en) 2025-10-09
AU2020363748A1 (en) 2022-04-28
CA3154225A1 (en) 2021-04-15
EP4445897A3 (en) 2025-01-15
MY206865A (en) 2025-01-10
US20240000706A1 (en) 2024-01-04
KR20220080165A (ko) 2022-06-14
US11759419B2 (en) 2023-09-19
CN114630653A (zh) 2022-06-14
AU2024201729A1 (en) 2024-04-04
US20210106521A1 (en) 2021-04-15
JP7574286B2 (ja) 2024-10-28
WO2021069036A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
CN114630653B (zh) 经压缩的烟碱锭剂
US12433881B2 (en) Nicotine tablet
CN111432840B (zh) 固体经口烟碱制剂
EP4447714B1 (en) Nicotine tablet
RU2825844C1 (ru) Прессованная никотиновая пастилка
RU2786451C2 (ru) Твердый пероральный никотиновый состав

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant